Screener
Integra LifeSciences IART Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) | $4,482 | $(484,073) | $(134) | $(509,366) |
| Net income (loss) per share | ||||
| Basic | $0.06 | $(6.31) | — | $(6.65) |
| Diluted | $0.06 | $(6.31) | — | $(6.65) |
| Weighted average common shares outstanding (See Note 12): | ||||
| Basic | 77,293 | 76,695 | 77,122 | 76,579 |
| Diluted | 78,168 | 76,695 | 77,122 | 76,579 |
| Comprehensive loss (See Note 13) | (4,775) | (490,874) | (10,254) | $(512,702) |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's shares (diluted)?
- Integra LifeSciences (IART) reported shares (diluted) of 78.2M in Q2 2026.
- How has Integra LifeSciences's shares (diluted) changed year-over-year?
- Integra LifeSciences's shares (diluted) increased by 1.9% year-over-year, from 76.7M to 78.2M.
- What is the long-term trend for Integra LifeSciences's shares (diluted)?
- Over 4 years (2021 to 2025), Integra LifeSciences's shares (diluted) has grown at a -2.7% compound annual growth rate (CAGR), from 341.5M to 306.6M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Integra LifeSciences's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude